| REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, ... New England Journal of Medicine 384 (3), 238-251, 2021 | 1765 | 2021 |
| REGEN-COV antibody combination and outcomes in outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, J Xiao, ... New England Journal of Medicine, 2021 | 624 | 2021 |
| The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies R Copin, A Baum, E Wloga, KE Pascal, S Giordano, BO Fulton, A Zhou, ... Cell 184 (15), 3949-3961. e11, 2021 | 201 | 2021 |
| Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV LW Musselwhite, V Sheikh, TD Norton, A Rupert, BO Porter, SR Penzak, ... AIDS (London, England) 25 (6), 787, 2011 | 104 | 2011 |
| Trial Investigators REGN-COV2, a Neutralizing Antibody Cocktail DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, ... Outpatients with Covid-19. N. Engl. J. Med 384, 238-251, 2021 | 80* | 2021 |
| HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx N Bloch, M O'Brien, TD Norton, SB Polsky, N Bhardwaj, NR Landau AIDS research and human retroviruses 30 (2), 195-203, 2014 | 61 | 2014 |
| REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, J Xiao, ... medRxiv, 2021 | 55 | 2021 |
| Inhibition of CUL4A Neddylation causes a reversible block to SAMHD1-mediated restriction of HIV-1 H Hofmann, TD Norton, ML Schultz, SB Polsky, N Sunseri, NR Landau Journal of virology 87 (21), 11741-11750, 2013 | 52 | 2013 |
| Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro TD Norton, EA Miller, N Bhardwaj, NR Landau Gene therapy 22 (3), 227-236, 2015 | 37 | 2015 |
| Lentiviral vector-based dendritic cell vaccine suppresses HIV replication in humanized mice TD Norton, A Zhen, T Tada, J Kim, S Kitchen, NR Landau Molecular Therapy 27 (5), 960-973, 2019 | 30 | 2019 |
| Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases AP Oppenheimer, C Koh, M McLaughlin, JC Williamson, TD Norton, ... World Journal of Gastroenterology: WJG 19 (1), 115, 2013 | 27 | 2013 |
| Recent advances in lentiviral vaccines for HIV-1 infection TD Norton, EA Miller Frontiers in immunology 7, 243, 2016 | 19 | 2016 |
| REGEN-COV Antibody Cocktail in Outpatients with Covid-19 DM Weinreich, S Sivapalasingam, T Norton, S Ali, H Gao, R Bhore, ... medRxiv, 2021 | 16 | 2021 |
| Attenuated Listeria monocytogenes Vectors Overcome Suppressive Plasma Factors During HIV Infection to Stimulate Myeloid Dendritic Cells to Promote Adaptive … EA Miller, MR Spadaccia, T Norton, M Demmler, R Gopal, M O'Brien, ... AIDS research and human retroviruses 31 (1), 127-136, 2015 | 14 | 2015 |
| Phase 2 dose-ranging study of the virologic efficacy and safety of the combination COVID-19 antibodies casirivimab and imdevimab in the outpatient setting C Portal-Celhay, E Forleo-Neto, W Eagan, BJ Musser, JD Davis, ... medRxiv, 2021 | 13 | 2021 |
| Chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism comprising the simian immunodeficiency virus (SIV) minimal Vpx … NR Landau, N Sunseri, TD Norton US Patent 9,149,519, 2015 | 11 | 2015 |
| In vitro and in vivo preclinical studies predict REGEN-COV protection against emergence of viral escape in humans R Copin, A Baum, E Wloga, KE Pascal, S Giordano, BO Fulton, A Zhou, ... bioRxiv, 2021 | 10 | 2021 |
| REGEN-COV protects against viral escape in preclinical and human studies R Copin, A Baum, E Wloga, KE Pascal, S Giordano, BO Fulton, A Zhou, ... bioRxiv, 2021 | 7 | 2021 |
| Lentiviral-Vector-Based Dendritic Cell Vaccine Synergizes with Checkpoint Blockade to Clear Chronic Viral Infection TD Norton, T Tada, R Leibowitz, V van der Heide, D Homann, NR Landau Molecular Therapy 28 (8), 1795-1805, 2020 | 6 | 2020 |
| Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection TD Norton, EA Miller Frontiers in immunology 7, 354, 2016 | 2 | 2016 |
